Barclays Maintains an 'Equalweight' on Boston Scientific (BSX); Additional Thoughts on CEO's Announced Departure and March Qtr 10-Q Review
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Boston Scientific (NYSE: BSX), PT $8.
Barclays analyst says, "BSX shares dropped ~9% (versus a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "BSX shares dropped ~9% (versus a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
